Senator Reverend Warnock Pressures Manufacturers, Insurers To Lower Insulin Costs To $35 A Month Or Less
March 15, 2023
March 15, 2023
WASHINGTON, March 15 -- Sen. Raphael G. Warnock, D-Georgia, issued the following news release and letters:
U.S. Senator Reverend Raphael Warnock (D-GA) called on insulin manufacturers and insurance companies to cap the out-of-pocket cost of insulin at $35 a month or less. The Senator sent letters to insulin manufacturers Novo Nordisk and Sanofi and insurers Blue Cross Blue Shield Association(BCBSA) Centene, Cigna, CVS Health, Kaiser Permanente, and Molina. Earlier in the month, Sena . . .
U.S. Senator Reverend Raphael Warnock (D-GA) called on insulin manufacturers and insurance companies to cap the out-of-pocket cost of insulin at $35 a month or less. The Senator sent letters to insulin manufacturers Novo Nordisk and Sanofi and insurers Blue Cross Blue Shield Association(BCBSA) Centene, Cigna, CVS Health, Kaiser Permanente, and Molina. Earlier in the month, Sena . . .